Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 2,502	$ 4,233
Trade accounts receivable, less allowance for doubtful accounts of $40 and $40, respectively	11,326	11,054
Prepaid expenses	5,845	3,480
Income taxes receivable	141	141
Other current assets	588	692
Total current assets	20,402	19,600
Net property and equipment	40,390	38,269
Intangible assets, net	2,519	2,616
Goodwill	66,152	66,152
Operating lease right-of-use assets	1,497	1,627
Deferred contract costs, net	1,538	1,562
Other noncurrent assets	2,677	2,713
Total assets	135,175	132,539
Current liabilities:
Current portion of notes payable, net of unamortized debt issuance costs	3,036	4,789
Revolving loan	3,500	0
Accounts payable	2,030	1,194
Accrued wages and bonuses	4,915	4,774
Accrued expenses	4,713	5,091
Dividends payable	2,735	2,770
Deferred revenue	15,507	15,786
Income taxes payable	274	353
Other current liabilities	1,064	1,101
Total current liabilities	37,774	35,858
Notes payable, net of current portion and unamortized debt issuance costs	58,669	57,895
Deferred income taxes	5,391	3,531
Other long-term liabilities	3,669	3,971
Total liabilities	105,503	101,255
Shareholders’ equity:
Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued	0	0
Common stock, $0.001 par value; authorized 110,000,000 shares, issued 31,082,158 in 2025 and 31,072,144 in 2024, outstanding 22,785,421 in 2025 and 23,083,116 in 2024	31	31
Additional paid-in capital	180,552	180,249
Retained earnings (accumulated deficit)	(14,012)	(17,064)
Treasury stock, at cost; 8,296,737 and 7,989,028 Common shares in 2025 and 2024, respectively	(136,899)	(131,932)
Total shareholders’ equity	29,672	31,284
Total liabilities and shareholders’ equity	$ 135,175	$ 132,539